213 related articles for article (PubMed ID: 1807117)
1. [Growing teratoma syndrome].
Urruchi Fernández P; Cavero Rebollo O; Jiménez Mas JA; Martínez Bengoechea J; González Enguita C; Rioja Sanz LA
Actas Urol Esp; 1991; 15(2):205-8. PubMed ID: 1807117
[TBL] [Abstract][Full Text] [Related]
2. [Growing teratoma syndrome in metastatic germinal non-seminomatous testicular tumors].
Alcaraz A; Arango O; Talbot-Wrigth R; Gelabert A; Ayuso C; Alvarez-Vijande R; Bielsa O; Vesa J; Carretero P
Actas Urol Esp; 1990; 14(3):239-42. PubMed ID: 2239407
[TBL] [Abstract][Full Text] [Related]
3. Testicular tumors: residual retroperitoneal mass surgery after chemotherapy;Is it possible to predict their histology?
Medina-Polo J; Martínez-Silva V; Domínguez-Esteban M; de la Rosa-Kehrmann F; Villacampa-Aubá F; Castellano-Gauna D; Díaz-González R
Arch Esp Urol; 2011 Sep; 64(7):611-9. PubMed ID: 21965259
[TBL] [Abstract][Full Text] [Related]
4. [Unusual development of nonseminomatous germ cell tumors of the testis (NSGCT)].
Caty A; Depadt G; Feutry ML
Bull Cancer; 1997 Aug; 84(8):796-9. PubMed ID: 9339184
[TBL] [Abstract][Full Text] [Related]
5. ["Growing teratoma syndrome": an unrecognized complication of treated germ cell tumors of the testis].
Ghaouti M; Roquet L; Fazzalari L; Sibert L; Sabourin JC
Ann Pathol; 2013 Dec; 33(6):402-5. PubMed ID: 24331722
[TBL] [Abstract][Full Text] [Related]
6. Teratoma in the orchiectomy specimen and volume of metastasis are predictors of retroperitoneal teratoma in low stage nonseminomatous testis cancer.
Foster RS; Baniel J; Leibovitch I; Curran M; Bihrle R; Rowland R; Donohue JP
J Urol; 1996 Jun; 155(6):1943-5. PubMed ID: 8618293
[TBL] [Abstract][Full Text] [Related]
7. [Successful management of choriocarcinoma of the testis with brain metastasis: a case report].
Kanematsu E; Kawamoto S; Yamamoto N; Takahashi Y; Iwata H; Saitoh A; Kuriyama M; Ban Y; Kawada Y
Hinyokika Kiyo; 1992 Oct; 38(10):1195-9. PubMed ID: 1282775
[TBL] [Abstract][Full Text] [Related]
8. Retroperitoneal lymph node dissection after chemotherapy.
Winter C; Raman JD; Sheinfeld J; Albers P
BJU Int; 2009 Nov; 104(9 Pt B):1404-12. PubMed ID: 19840021
[TBL] [Abstract][Full Text] [Related]
9. Long-term clinical outcome after postchemotherapy retroperitoneal lymph node dissection in men with residual teratoma.
Carver BS; Shayegan B; Serio A; Motzer RJ; Bosl GJ; Sheinfeld J
J Clin Oncol; 2007 Mar; 25(9):1033-7. PubMed ID: 17261854
[TBL] [Abstract][Full Text] [Related]
10. Retroperitoneal lymph node dissection (RPLND) post chemotherapy for non-seminomatous testicular neoplasms: what is the significance of residual masses at scanner control after chemotherapy and should they be removed?
Solé-Balcells F; Villavicencio H; Germá R
Prog Clin Biol Res; 1989; 303():759-62. PubMed ID: 2780671
[No Abstract] [Full Text] [Related]
11. Teratoma in primary testis tumor reduces complete response rates in the retroperitoneum after primary chemotherapy. The case for primary retroperitoneal lymph node dissection of stage IIb germ cell tumors with teratomatous elements.
Rabbani F; Gleave ME; Coppin CM; Murray N; Sullivan LD
Cancer; 1996 Aug; 78(3):480-6. PubMed ID: 8697394
[TBL] [Abstract][Full Text] [Related]
12. [Burned-out testicular tumor: a case report].
Sugiyama T; Hirano Y; Ushiyama T; Suzuki K; Fujita K; Ohmi Y
Hinyokika Kiyo; 2000 Nov; 46(11):829-32. PubMed ID: 11193307
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour.
Shayegan B; Carver BS; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
BJU Int; 2007 May; 99(5):993-7. PubMed ID: 17437432
[TBL] [Abstract][Full Text] [Related]
14. Growing teratoma syndrome: experience of a single institution.
Maroto P; Tabernero JM; Villavicencio H; Mesía R; Marcuello E; Solé-Balcells FJ; Sola C; Mora J; Algaba F; Pérez C; León X; López López JJ
Eur Urol; 1997; 32(3):305-9. PubMed ID: 9358218
[TBL] [Abstract][Full Text] [Related]
15. [Case of immature teratoma of the testicle metastasizing as completely mature teratoma].
Okumura S; Ohhara M; Sugizawa Y; Hirasawa S; Tsuboi N; Yoshida K; Nishimura T; Akimoto M
Hinyokika Kiyo; 1984 May; 30(5):683-9. PubMed ID: 6206705
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of patients with retroperitoneal metastases of nonseminoma tumors of the testis].
Matveev BP; Figurin KM
Vopr Onkol; 1988; 34(12):1493-7. PubMed ID: 2464238
[TBL] [Abstract][Full Text] [Related]
17. Relevance of biochemical tumor markers and lymphadenectomy in management of non-seminomatous testis tumors: current perspective.
Skinner DG; Scardino PT
Trans Am Assoc Genitourin Surg; 1979; 71():31-5. PubMed ID: 94715
[No Abstract] [Full Text] [Related]
18. [Urologic treatment of testicular germ cell cancer].
Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
[TBL] [Abstract][Full Text] [Related]
19. Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection.
Carver BS; Shayegan B; Eggener S; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
J Clin Oncol; 2007 Oct; 25(28):4365-9. PubMed ID: 17906201
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome for patients with high volume retroperitoneal teratoma undergoing post-chemotherapy surgery.
Beck SD; Foster RS; Bihrle R; Einhorn LH; Donohue JP
J Urol; 2009 Jun; 181(6):2526-32. PubMed ID: 19371895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
